Keywords: lilly, chief, makes, case, pharma, don, stifle

Lilly chief makes case for US Pharma; "don't stifle innovation via reforms"

Article | 15 May 2009

Print This

US federal policymakers' attention to access, quality and costs in health reform should also include a focus on innovation - ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in